<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04862507</url>
  </required_header>
  <id_info>
    <org_study_id>I-LAST</org_study_id>
    <nct_id>NCT04862507</nct_id>
  </id_info>
  <brief_title>Improving Low ASPECTS Stroke Thrombectomy</brief_title>
  <acronym>I-LAST</acronym>
  <official_title>Improving Low Alberta Stroke Program Early ct Score Stroke Thrombectomy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Universitätsklinikum Hamburg-Eppendorf</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of Kaiserslautern</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University Hospital Muenster</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Rostock</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University Hospital, Basel, Switzerland</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Charite University, Berlin, Germany</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Klinikum Bremen-Mitte, gGmbH</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Universitätsklinikum Hamburg-Eppendorf</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Improving Low ASPECTS Stroke Thromectomy (I-LAST) is an academic, independent, prospective,&#xD;
      multicenter, observational registry study. Consecutive patients treated with endovascular&#xD;
      stroke treatment will be enrolled in German stroke centers. Patients receive regular care and&#xD;
      data will be collected as part of clinical routine. Baseline clinical and procedural&#xD;
      information as well clinical follow-up information during in-hospital stay, and up to 90 days&#xD;
      of stroke onset are collected. Data collected include demographics, National Institute of&#xD;
      Health Stroke Scale (NIHSS) on admission, pre-treatment ASPECTS, information on timing and&#xD;
      success of interventional treatment, procedural complications, intracranial hemorrhage, and&#xD;
      functional outcome. Advanced imaging biomarkers will be tested and validated aiming to&#xD;
      improve treatment selection and outcome prediction of patients presenting with extensive&#xD;
      baseline infarction.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study aims to investigate the role of advanced imaging biomarkers in patients with large&#xD;
      early infarct, in particular quantitative lesion water uptake (Minnerup et al. Annals of&#xD;
      Neurology 2016), arterial and venous collateral circulation (Faizy et al. Radiology 2021),&#xD;
      and multivariate CTP-derived parameters (Kemmling et al. JCBFM 2015). The goal is to use&#xD;
      these imaging biomarkers as specific selection criterion to predict clinical benefit after&#xD;
      reperfusion despite extensive baseline infarct lesions, also as a method of monitoring&#xD;
      adjuvant neuroprotective agents after reperfusion therapy (for instance anti-edematous&#xD;
      medication).&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">December 1, 2021</start_date>
  <completion_date type="Anticipated">April 1, 2026</completion_date>
  <primary_completion_date type="Anticipated">April 1, 2023</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>90 Days</target_duration>
  <primary_outcome>
    <measure>modified ranking scale on day (mRs) day 90</measure>
    <time_frame>90 days</time_frame>
    <description>mRs: modified ranking scale; the scale is a commonly used measurement for the degree of disability or dependence in the daily activities of people who have suffered a stroke; scale range 0-6, with 0 - No symptoms. 1 - No significant disability. Able to carry out all usual activities, despite some symptoms. 2 - Slight disability. Able to look after own affairs without assistance, but unable to carry out all previous activities. 3 - Moderate disability. Requires some help, but able to walk unassisted. 4 - Moderately severe disability. Unable to attend to own bodily needs without assistance, and unable to walk unassisted. 5 - Severe disability. Requires constant nursing care and attention, bedridden, incontinent. 6 - Dead. publication: van Swieten J, Koudstaal P, Visser M, Schouten H, et al. (1988). &quot;Interobserver agreement for the assessment of handicap in stroke patients&quot;. Stroke. 19 (5): 604-607. doi:10.1161/01.str.19.5.604.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Ischemic lesion water uptake on admission</measure>
    <time_frame>0-24 hours after symptom onset</time_frame>
    <description>Ischemic lesion water uptake is a CT based quantitative imaging biomarker to assess ischemic edema based on densitometry</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Ischemic lesion water uptake on follow-up imaging</measure>
    <time_frame>24-48 hours after admission</time_frame>
    <description>Ischemic lesion water uptake is a CT based quantitative imaging biomarker to assess ischemic edema based on densitometry</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">500</enrollment>
  <condition>Acute Ischemic Stroke</condition>
  <arm_group>
    <arm_group_label>Stroke Patients with an ASPECTS of 0-5 on baseline neuroimaging undergoing thrombectomy</arm_group_label>
    <description>acute stroke patients treated with endovascular treatment combined with thrombolysis or without previous thrombolysis Intervention.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Stroke Patients with an ASPECTS of 0-5 on baseline neuroimaging not undergoing thrombectomy</arm_group_label>
    <description>acute stroke patients treated with or without thrombolysis</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Telephone call on day 90</intervention_name>
    <description>telephone call on day 90 to assess the primary outcome (mRs 90)</description>
    <arm_group_label>Stroke Patients with an ASPECTS of 0-5 on baseline neuroimaging not undergoing thrombectomy</arm_group_label>
    <arm_group_label>Stroke Patients with an ASPECTS of 0-5 on baseline neuroimaging undergoing thrombectomy</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Quantification of lesion water uptake by CT densitometry</intervention_name>
    <description>Retrospective quantification of lesion water uptake by CT densitometry in admission and follow-up imaging</description>
    <arm_group_label>Stroke Patients with an ASPECTS of 0-5 on baseline neuroimaging not undergoing thrombectomy</arm_group_label>
    <arm_group_label>Stroke Patients with an ASPECTS of 0-5 on baseline neuroimaging undergoing thrombectomy</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        All acute stroke patients with the clinical diagnosis of acute ischemic stroke with a&#xD;
        ASPECTS 0f 0-5 on baseline imaging; Age &gt;18 years&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Clinical diagnosis of acute ischemic stroke&#xD;
&#xD;
          -  ASPECTS of 0-5&#xD;
&#xD;
          -  Confirmed diagnosis of persistent occlusion of terminal carotid artery, middle&#xD;
             cerebral artery (M1 or M2), or basilar artery consistent with symptoms&#xD;
&#xD;
          -  Age &gt;18 years&#xD;
&#xD;
          -  Ethic approval in process&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        none&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Gabriel Broocks, MD</last_name>
    <phone>+4915222817182</phone>
    <email>g.broocks@uke.de</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Andre Kemmling, MD, MHBA</last_name>
    <email>akemmling@gmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Charite University Berlin</name>
      <address>
        <city>Berlin</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Bremen-Mitte</name>
      <address>
        <city>Bremen</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Medical Center Hamburg-Eppendorf</name>
      <address>
        <city>Hamburg</city>
        <zip>20251</zip>
        <country>Germany</country>
      </address>
    </facility>
    <contact>
      <last_name>Gabriel Broocks, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Westpfalzklinikum</name>
      <address>
        <city>Kaiserslautern</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Münster</name>
      <address>
        <city>Münster</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Rostock</name>
      <address>
        <city>Rostock</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Basel</name>
      <address>
        <city>Basel</city>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
    <country>Switzerland</country>
  </location_countries>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>April 13, 2021</study_first_submitted>
  <study_first_submitted_qc>April 22, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">April 28, 2021</study_first_posted>
  <last_update_submitted>September 28, 2021</last_update_submitted>
  <last_update_submitted_qc>September 28, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 29, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Universitätsklinikum Hamburg-Eppendorf</investigator_affiliation>
    <investigator_full_name>Gabriel Broocks</investigator_full_name>
    <investigator_title>Assistant Professor, Principal Investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Stroke</mesh_term>
    <mesh_term>Ischemic Stroke</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
    <ipd_description>Data will be shared upon reasonable request.</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

